Andrew Grulich

Andrew Grulich leads HIV epidemiology research at the Kirby Institute, where his studies have documented the elevated cancer risk in people living with HIV, including both AIDS-defining and non-AIDS-defining malignancies. His research on the interaction between HIV immunosuppression and oncogenic viruses like HPV, EBV, and HHV-8 has revealed how co-infections amplify cancer risk in tropical and resource-limited settings. His work on anal cancer screening in HIV-positive populations has informed clinical guidelines internationally.